We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for patients, healthcare professionals and developers of new medicines
A 5-year deal setting out how community pharmacy will support delivery of the NHS Long Term Plan.
Guidance on registration of medical devices that are reusable or upclassified Class I devices, and/or reliant on expired or expiring CE certificates.
A poster explaining the different symbols used on medical devices.
How to comply with the regulatory requirements for manufacturing custom-made medical devices.
A flyer to circulate to customers alongside a field safety notice covering what it is and why it's important to take action.
Guidelines to provide developers of biosimilar products with a clear outline of the requirements in Great Britain.
How to apply to have nutritional or dermatological products reviewed by the Advisory Committee on Borderline Substances (ACBS).
The MHRA's initial plans on an Early Access service, which will be developed further throughout 2025.
How the MHRA treats traditional herbal medicines and homeopathic medicines.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
How to use PharmaQC to access pharmaceutical suppliers, Quality Control (QC) pharmacists and Commercial Medicines Unit (CMU) buyers.
An overview of the legal requirements for children’s medicines that Marketing Authorisation Holders (MAHs) need to abide by.
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore the Non-Compressible Haemorrhage (NCH) environment. To understand who is doing work in this area and possible novel solutions of treatmen…
Actions QPs, RPis and RPs need to take following agreement of the Windsor Framework
Apply for and maintain registrations for the brokering of human medicines.
What you need to do to supply authorised medicines from Great Britain to Northern Ireland.
Recommendations for prescribing methadone and buprenorphine to people in treatment for opioid dependence in England.
This publication clarifies which regulatory guidelines should be followed, and which apply, in the development of phage therapeutic products.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).